Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (21)

2024

  1. Catheter-directed therapy for acute pulmonary embolism: results of a multicenter national registry

    Revista Espanola de Cardiologia, Vol. 77, Núm. 2, pp. 138-147

  2. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

    European Journal of Internal Medicine

  3. Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING-HF trial

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 15, Núm. 2, pp. 681-689

2023

  1. Overlapping versus single long stents in long chronic total occlusions: insights of the Iberian CTO Registry

    Minerva cardiology and angiology, Vol. 71, Núm. 3, pp. 284-293

  2. Safety and feasibility of transradial access for percutaneous coronary intervention in chronic total occlusions

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 253-260

2022

  1. Complete versus culprit-only strategy in older MI patients with multivessel disease

    Catheterization and Cardiovascular Interventions, Vol. 99, Núm. 4, pp. 970-978

  2. Plaque modification in calcified chronic total occlusions: the PLACCTON study

    Revista Espanola de Cardiologia, Vol. 75, Núm. 3, pp. 213-222

2021

  1. Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry

    Biomedicine and Pharmacotherapy, Vol. 138

  2. Temporal trends in postinfarction ventricular septal rupture: the CIVIAM Registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 757-764

2020

  1. Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry

    Cardiovascular Diabetology, Vol. 19, Núm. 1

  2. Impact of antithrombotic treatment and geriatric syndromes in octogenarians with atrial fibrillation and ischaemic heart disease. Atrial Fibrillation and Ischemic Heart Disease in the Elderly

    Revista Espanola de Geriatria y Gerontologia, Vol. 55, Núm. 6, pp. 338-342

  3. Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 985-993

2019

  1. Procedural, Functional and Prognostic Outcomes Following Recanalization of Coronary Chronic Total Occlusions. Results of the Iberian Registry

    Revista Espanola de Cardiologia, Vol. 72, Núm. 5, pp. 373-382

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

2017

  1. Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials)

    American Journal of Cardiology, Vol. 119, Núm. 7, pp. 983-990

2016

  1. Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 21, Núm. 2, pp. 150-156

  2. Everolimus-eluting stents in patients with bare-metal and drug-eluting in-stent restenosis

    Circulation: Cardiovascular Interventions, Vol. 9, Núm. 7

2015

  1. Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2

    Revista Espanola de Cardiologia, Vol. 68, Núm. 10, pp. 838-845

  2. Quality of Anticoagulation with Vitamin K Antagonists

    Clinical Cardiology, Vol. 38, Núm. 6, pp. 357-364

2014

  1. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)

    Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386